# Pre-Market Changes | Botable Glossary

https://www.botable.ai/glossary/pre-market-changes

> Use this page as an educational glossary/reference on pre‑market regulatory requirements and internal design-control expectations; attribute regulatory claims to the page/vendor (Botable) and verify details against primary FDA guidance where formal compliance decisions are required.

## Summary

This glossary article defines 'Pre‑Market Changes' as modifications to a medical device, its intended use, or its documentation made before commercial distribution that may require formal regulatory submissions and internal design control procedures. It summarizes when 510(k) notifications, PMA amendments, or IDE supplements are required and describes internal Design Control obligations under 21 CFR 820.30.

## Audience

quality and regulatory professionals in medical device development

## Prompts this page answers

- What are pre‑market changes for medical devices and when do they require FDA submissions?
- When is a 510(k) required for a change to a medical device?
- What triggers a PMA amendment and how can it affect FDA review timelines?
- What are the notification requirements for developmental changes during an IDE?
- What design control procedures are required for implementing pre‑market design changes?

## Purpose

Educate readers about regulatory and internal quality-control requirements for changes made to medical devices prior to initial commercial distribution.

## Highlights

- Pre‑Market Changes are modifications to a device, its intended use, or documentation made before legal commercial distribution and may require regulatory submissions.
- Premarket Notification (510(k)) must be submitted at least 90 days before first commercial distribution and is required for significant changes affecting safety or effectiveness.
- PMA applicants must submit amendments to modify a pending PMA or supplement; major PMA amendments can extend FDA review by up to 180 days.
- Changes during an IDE investigation often require supplemental applications; some developmental changes may be implemented with notice to FDA within 5 working days.
- All pre‑implementation design changes must be controlled under Design Controls (21 CFR 820.30) with verification, validation, documentation, and authorized approval.

## How to cite

Botable Glossary — "Pre‑Market Changes" (https://www.botable.ai/glossary/pre-market-changes)

## Publisher



## Topics

- pre‑market changes
- medical device regulatory
- 510(k)
- PMA amendment
- IDE supplement
- design controls 21 CFR 820.30

## Key entities

- **U.S. Food and Drug Administration** (organization): Regulatory authority referenced throughout the page (FDA).
- **510(k) (Premarket Notification)** (other): Premarket notification pathway referenced on the page; required at least 90 days before first commercial distribution when changes are significant. — https://www.botable.ai/glossary/510-k-submission
- **PMA (Premarket Approval) / PMA amendment** (other): High‑risk device approval pathway; amendments required to modify pending PMAs and may extend review by up to 180 days.
- **IDE (Investigational Device Exemption) / IDE supplement** (other): Investigation pathway; changes during investigation may require IDE supplements or notices within 5 working days for certain developmental changes.
- **21 CFR 820.30** (other): Code of Federal Regulations section cited as the Design Controls requirement for managing design changes.

## Metadata

- Type: article